Retatrutide, developed by Eli Lilly under the code LY3437943, is a synthetic peptide that simultaneously activates three incretin and metabolic receptors: GLP-1, GIP, and glucagon
This powerful, safe, and effective peptide therapy reverses problems with a slow metabolism, low sex drive, lean muscle loss, low bone density, and excess weight
These hormones tell the ovaries to release an egg
The primary mechanism of action is the immediate neutralization of reactive oxygen species (ROS) at the cellular level
When to Adjust Dosing Increase dose if: After 4-6 weeks at current dose, no measurable body composition changes occur, youre tolerating current dose without side effects, youre below the upper clinical range (1 mg daily), and your physician approves escalation based on comprehensive assessment
Administration and Monitoring Administration Intravenous Reconstituted tesamorelin solution should always be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit